Open Government Portal
List of terms used in the guidance document.
This guidance document is intended to help importers, distributors, manufacturers and other establishments meet their regulatory requirements.
During the COVID-19 pandemic, Health Canada is working closely with domestic and international partners to anticipate and meet Canadians' health …
As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures …
During the COVID-19 pandemic, we continue to take a risk-based approach to inspections.
Learn how we conduct inspections of human cell, tissue and organ (CTO) establishments.
Any drugs sold to Canadians must remain safe and effective after they are approved for prescription and sale. Learn about …
Canada aims to reduce the risks to participants who enroll in clinical trials. Learn about clinical trial inspections and how …
Canada aims to protect the safety of Canadian blood donors and recipients. This is done by monitoring and inspecting establishments …
This policy provides general information to any person – an individual or an organization that is involved in the import, …